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Background: Recently, an established “small macrophage” phenotype has been observed in the sputum of patients with CF and COPD. However,
little is known about the prevalence of this phenotype in the airways of young children. Since respiratory inﬂammation begins early in CF, we
hypothesised that these small macrophages would be increased in paediatric CF bronchoalveolar lavage (BAL).
Methods: Macrophage populations in CF and disease control BAL were assessed by multicolour ﬂow cytometry. BAL inﬂammatory indices were
collected as part of the AREST-CF programme.
Results: Small macrophages were present in CF (n=35, mean 36±12% of BAL macrophages) but not signiﬁcantly different to the respiratory
disease controls (n=7, mean 40±21%). Number of small macrophages correlated signiﬁcantly with number of BAL neutrophils (r=0.44,
pb0.01) but not infection or IL-8.
Conclusions: In paediatric patients small macrophages are not unique to CF, but their establishment as the dominant phenotype in adults may be
due to chronicity of inﬂammation and infection.
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The pulmonary epithelium is essentially open to the external
environment and the lungs have well developed host defence
systems responsible for maintaining homeostasis. An important
part of these host defences is the ability to identify and clear
particulate matter and potentially pathogenic microorganisms
with minimal harm to the airways and alveolar spaces. Cellular
components of the innate immune system, including macro-
phages and neutrophils, are integral to this defence. Alveolar
macrophages (AM) are a motile and heterogeneous first lineby Elsevier B.V. All rights reserved.
Table 1
Demographic details of the study population.
Disease Controls (n=7) Cystic Fibrosis (n=35)
Age years (mean±sd) 3.6 ±2.0 3.4±1.9
Gender 3 Male / 4 Female 17 Male / 18 Female
Pulmonary Infection (n) P. aeruginosa (0) P. aeruginosa (2)
S. aureus (1) Mixed oral flora (12)
H. influenzae (1) A. fumigatus (3)
S. pneumoniae (1) Candida species (3)
H. influenzae (2)
S. maltophilia (2)
Gram negative bacilli (1)
MRSA (1)
S. aureus (1)
S. pneumoniae (1)
Scedosporium species (1)
202 L.W. Garratt et al. / Journal of Cystic Fibrosis 11 (2012) 201–208of defence, whose roles include ingesting foreign particles,
presenting antigens to the immune system and regulating the
immune response [1,2]. Mucosal dwelling AM are the most
abundant cell type found in bronchoalveolar lavage obtained
from healthy individuals, constituting more than 80% of im-
mune cells [3-6].
In chronic lung diseases the normal size distribution of AM
appears to be changed. Numbers of monocyte-like cells are sig-
nificantly increased in the alveolar space during both chronic
inflammatory lung diseases such as interstitial pulmonary fibro-
sis and collagen vascular diseases [7] and in long term smokers
[8]. More recently, Frankenberger et al. observed a population
of macrophages that were smaller and less granulated in in-
duced sputum of adults with chronic obstructive pulmonary
disease (COPD) [9] and had high surface expression of CD14
and HLA-DR, as well as increased expression of tumour necro-
sis factor α (TNF α). These small macrophages accounted for
45% of all macrophages in sputum from adults with COPD
compared to 7% from control subjects. The authors attributed
this discrepancy to depletion of conventional AM, proposing
that these small macrophages are newly recruited monocytes
with lower phagocytic but enhanced inflammatory capacity.
Small macrophages were then identified in the sputum
of adults with cystic fibrosis (CF), accounting for 73% of all
macrophages in comparison to 16% in healthy controls [10].
Further analysis revealed these small macrophages in CF
sputum lacked the scavenger receptor MARCO, resulting in
deficient phagocytosis when assessed by the uptake of fluoro-
sphere particles. Thus it has been hypothesised that the inabil-
ity of small macrophages to effectively clear the airways of
foreign organisms and particles, in conjunction with constitu-
tive expression of inflammatory mediators, may facilitate the
establishment of infection and inflammatory damage in the
airways.
Wright et al. [10] also observed that small macrophages were
prevalent in older children with CF (mean age 12.2 years±3),
but due to the difficulties in obtaining sputum this was not
further investigated. Young children with CF cannot reliably
expectorate sputum until 7 or 8 years of age, precluding the as-
sessment of lung macrophages in early lung disease by sputum
collection. However, infection and inflammation are present
early in CF and lung disease can be observed even within the
first weeks of life [11]. In these children bronchoalveolar lavage
(BAL) permits assessment of lower respiratory tract infection
and the associated inflammatory processes [12]. Cellular assess-
ment of lavage fluid by flow cytometry is well defined [6,13-15]
and in adult BAL fluid a similar monocyte-like population
has previously been identified [16]. Little is known about the
prevalence of small macrophages in the lungs of young children.
Utilising the unique early surveillance program conducted by
the Australia Respiratory Early Surveillance Team for Cystic
Fibrosis (AREST CF), we aimed to verify whether small macro-
phages were present in the lungs of infants and young children
with CF and investigate their relationship with infection and
inflammation. We hypothesised that small macrophages would
account for an increased proportion of macrophages in the
BAL of children with CF.2. Methods
Children participating in the AREST-CF early surveillance
program at Princess Margaret Hospital for Children, Perth,
Australia were recruited for this study. Details of this surveil-
lance program have been published elsewhere [17–18] but,
briefly: assessments including BAL are conducted soon after
diagnosis and then annually until 6 years of age when children
are clinically stable with no current exacerbation of lung dis-
ease. The diagnosis of CF was confirmed by sweat test [19],
following detection by either newborn screening or by clinical
presentation. Children without CF who were undergoing BAL
for investigation of persistent respiratory symptoms (Table 1)
were recruited as disease controls.
Adults with CF (n=5) who were hospitalised at Sir Charles
Gairdner Hospital, Perth, for treatment of respiratory exacerba-
tions were recruited to provide spontaneous sputum samples as
positive controls. The project was approved by the institutional
ethics committees of both Princess Margaret and Sir Charles
Gairdner hospitals and written consent was obtained for sam-
ples to be used for research purposes.
2.1. BAL processing
Bronchoscopy and BAL were conducted under general
anaesthetic as previously reported [17] and according to recom-
mendations by the European Respiratory Society Task Force on
BAL in children [20]. Briefly, BAL was performed in the right
middle lobe (RML) (3 aliquots of 1 mL/kg to a maximum of
20 mL) and a single aliquot from the lingula, or the worst af-
fected lobe as determined by low dose computer tomography
(CT) imaging. Blood was collected under anaesthetic for rou-
tine clinical purposes, including the whole blood white cell
count. The initial aliquot from each site was processed separate-
ly for detection of bacteria, fungi, viruses and inflammation
using standard clinical methodology as described elsewhere
[21]. Significant infection was defined as >104 colony forming
units (CFU)/mL−1, whilst a density of 102–104 CFU/mL−1
was recorded as “isolated colonies”. The second and third
Fig. 1. Flow chart of identifying macrophage population for assessing size dis-
tribution. Sputum or BAL cells were stained with anti-CD14-APC, anti-HLA-
DR-PerCP, anti-CD66b-FITC, anti-CD68-PE and anti-CD45-APC-Cy7 and
data acquired by flow cytometry. The flow chart depicts the process of selecting
the lung macrophage population of interest following acquisition.
203L.W. Garratt et al. / Journal of Cystic Fibrosis 11 (2012) 201–208aliquots from the RML were combined and after removing
supernatant for storage following centrifugation at 300 g, total
cell and viability counts were obtained using a haemocytometer
and trypan blue staining. Cell pellets were then resuspended
to 1×106 cells per mL for cytospins and differential counting
after Leishmann's stain. The remaining cell suspension was
processed for staining and flow cytometry analysis.
2.2. Inflammation assessment
IL-8 was measured using a commercial ELISA (BD
OptEIA, BD Biosciences, San Diego, CA, USA; detection
limit 20 pg/mL−1). Neutrophil elastase activity was measured
by a modified enzymatic assay using N-succinyl Ala-Ala-Pro-
Val as the specific substrate; the limit of the assay was
0.2 μg/mL−1. Samples below the lower limit of detection
were arbitrarily assigned a value of half the lower limit of
detection, in order to minimise the difficulties associated with
statistical analysis of zero values. Whole blood white cell
count was assessed by standard clinical procedure.
2.3. Sputum processing
Sputum was examined visually for colour and consistency
and processed using a previously described method [22].
Sputum was separated from saliva by sterile forceps and the
weight of the selection was determined. To facilitate the break-
down of the sputum sample, 6.5 mM dithiothreitol (DTT:
Sigma Chemicals, St Louis, MO, USA) in laboratory grade
phosphate buffered saline (PBS) was prepared freshly. A vol-
ume of DTT equal to four times the weight of sputum was
added and the solution vortexed vigorously in intervals over a
period of 15 minutes. Later, an equal volume of PBS was
added and the solution mixed. The whole sample was passed
twice through pre-wetted, non-sterile nylon gauze (Sefar Filter
Specialists, Huntingwood, NSW, Australia) and cotton wool
(BSN Medical, Mt Waverly, Victoria, Australia) filter that were
placed inside a 20 mL syringe (Terumo, Laguna, Philippines)
and followed by a wash with 5 mL of PBS. The filtered cells
were centrifuged at 800 g for 10 min at 4 °C and the supernatant
was discarded. The cell pellet was resuspended in 2 mL of PBS
and 10 μL mixed with an equal volume of filtered 0.4% Trypan
Blue (Sigma Chemicals, St Louis, MO, USA) to determine total
cell count and viability. Cell pellets were later resuspended to
1×106 cells per mL for cytospins and differential counting after
Leishmann's stain.
2.4. Flow cytometry
Following processing, sputum or BAL cell suspensions
were resuspended to 1×106 cells per mL of PBS and then stained
for 30 min at room temperature in 100 μL volumes with FITC-
conjugated CD66b (BD Biosciences, San Diego, CA, USA),
APC-conjugated CD14 (Biolegend, San Diego, CA, USA),
APC-Cy7-conjugated CD45 (Biolegend, San Diego, CA, USA)
and PerCP-conjugated HLA-DR (Biolegend, San Diego, CA,
USA). Single stain and unstained controls were performed.Following a wash with 1 mL PBS, the cells were resuspended
in 250 μL of Cytofix/Cytoperm (BD Biosciences, San Diego,
CA, USA) and incubated on ice for 20 min to fix cell surface
bound antibodies. Cells were permeabilised utilising Perm/
Wash Buffer kit (BD Biosciences, San Diego, CA , USA) and
stained with PE-conjugated intracellular CD68 (BD Biosci-
ences, San Diego, CA, USA) for 30 min on ice with light protec-
tion. A final wash was performed and cells were resuspended in
500 μL PBS and all cells were acquired on a BD LSR2 flow cyt-
ometer (BD Biosciences, San Diego, CA, USA). Data collected
were later analysed on FlowJo (Tree Star Inc, Ashland, OR,
USA) with selection gates set so that less than 2% of blank
and single-stain control events were selected. Healthy control
BAL fluid and sputum were unavailable. To minimise bias, ar-
bitrary, uniform gates were set for all samples within the same
sample type (sputum or BAL) and were based upon consensus
of samples with a normal and expected initial scatter profile.
2.5. Identification of small macrophages by flow cytometry
Sputum from adult CF patients and BAL from the paediatric
subjects were analysed based upon previously published
methods [9] and is outlined in Fig. 1. Briefly, the appearance
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Cells of macrophage lineage were then identified by selecting
for positive CD14 expression and these were confirmed to be
leukocytes by positive CD45 expression. To prevent CD14low
granulocytes contaminating the final analysis, granulocytes
were excluded by gating for positive HLA-DR expression and
absence of CD66b expression. Finally this population was re-
fined for positive CD68 expression. This final population of
CD14+/CD45+/HLA-DR+/CD66b-/CD68+ macrophages was
assessed by size for macrophage sub-populations as reported
in the literature and after gating identically between samples,
the proportions (of total sputum macrophages) were measured
and compared.
2.6. Statistical analysis
Data were assessed for normality and those not normally
distributed were log10 transformed. Correlations were assessed
using Pearson product moment test and differences between
groups were assessed by unpaired t-test. Statistical significance
was interpreted as a p-value of b0.05. Statistical analyses
were performed using GraphPad Prism v5 (GraphPad Software,
San Diego).
3. Results
3.1. Study population
The study population consisted of 35 children with CF who
were having a clinically directed BAL for annual assessment,
and 7 disease controls, who were undergoing a clinically direct-
ed exploratory BAL for recurrent infections (n=4), assessment
for airway malacia (n=2) and investigation of bronchiectasis
(n=1).
There were no differences in total cell count or inflammatory
cellular profile between the children with CF and disease con-
trols (Table 2), nor was there any difference observed in these
metrics between male and female subjects (data not shown).
3.2. Technique validation in sputum
The analysis of adult sputum revealed a predominantly
smaller phenotype (representative sample, Fig. 2a) in 4 out of
5 samples, with a calculated mean of 74.5% (±sd 8.3 [rangeTable 2
Cellular profiles of BAL from children with CF and disease controls.
Disease Controls
(n=7)
Cystic Fibrosis
(n=35)
Total Cell Count (cells×106±sd) 4.32±1.68 4.95±0.9 ns
Viability %±sd 80.8±4.2 79.7±1.6 ns
Lung Macrophages %±sd 70.5±11.4 70.9±3.6 ns
Lung Granulocytes %±sd 18±11.8 25.5±3.5 ns
Lung Small macrophage %±sd 40±21.3 35.6±11.8 ns
Lung Large macrophage %±sd 59.6±21.8 63.9±12 ns
Blood Monocytes %±sd 9.7±1 8±2.1 ns
Blood Neutrophils %±sd 43.1±16.9 38.4±13.2 ns65–82%]) small macrophages. In comparison the remaining
adult CF sputum sample displayed a predominantly large AM
phenotype (Fig. 2b) and thus fewer (23%) small macrophages
were measured. However the observation of predominantly
small macrophages in the majority of adult CF sputum samples,
as reported previously [10] suggests that we successfully vali-
dated our technique to assess macrophage populations by
flow cytometry.
Using an approach comparable to the adult sputum analysis
described above, the paediatric CF and disease control BAL
samples were prospectively collected and assessed for small
macrophages. Clear separation between small and large macro-
phage populations, as demonstrated in sputum previously in the
literature and in our own adult samples, were not observed in
these BAL samples making analysis difficult (representative
sample, Fig. 3a and b respectively). Due to this observation, ar-
bitrary size selection gates were created to define macrophages
as small or large and were applied identically to both CF and
disease control samples.
Results showed that there was no significant difference
between the two study groups, with a mean (SD) of 35.6%
(11.82% [13–57%]) small macrophages recorded for the CF
group and 40% (21.13% [14–70%]) for the non-CF control
respectively. Within our paediatric CF group, there was no
significant correlation between the proportion of small macro-
phages and a number of disease indices. Briefly, the prevalence
of small macrophages did not increase with age (rb0.01,
p=0.73). Small macrophages did not have any significant asso-
ciation with infection as defined by >104 CFU/mL in the BAL
fluid (uninfected 36.6% small macrophages vs infected 32.9%,
p=0.65, student's t-test). The majority of BALs assessed were
culture negative for Pseudomonas species (91.4%), thus pre-
venting assessment of this relationship. Nine (25.7%) of the
CF subjects exhibited respiratory symptoms at the time of
BAL, however those children with symptoms were not found
to have a significantly different number of small macrophages
(asymptomatic 34.5% small macrophages vs symptomatic
38.8%, p=0.36, student's t-test). No relationship was observed
with either of the inflammation markers IL-8 (r=0.18, p=0.31)
or neutrophil elastase (r=−0.25, p=0.15).
Assessing interactions with other cell populations revealed
a significant positive correlation between the absolute number
of small macrophages and the absolute number of neutrophils
(r=0.44, pb0.01, Fig. 4). Trends were also observed between
the percentage of small macrophages in BAL and the percent-
age of monocytes in the blood white cell count pool (r=0.31,
p=0.062; Fig. 5), and decreased BAL cell viability (r=0.31,
p=0.067) but neither reached statistical significance.
4. Discussion
In the present study we have been able to confirm previous
observations that small macrophages are elevated in adult CF
sputum, thus confirming our methodology. We have then dem-
onstrated that small macrophages, similar to those described
in adults with CF, are present in BAL obtained from young
children with CF and from children being investigated for
Fig. 2. Small macrophages in adult sputa. This figure provides a comparison between adult CF sputum with predominantly small macrophage (a) and adult CF
sputum with predominantly large AMΦ (b).
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tween children with and without CF and the lower proportion
of these cells seen in children compared to previously reported
chronically infected adults suggest that these small macro-
phages are not specific to CF. The ratio between small macro-
phages and large macrophages was not influenced by the
presence of lower respiratory infection in these young children,
although the small numbers of infected children limited the
assessment of this relationship. In absolute terms, the number
of small macrophages did correlate with neutrophils, suggest-
ing that small macrophages are recruited to the airways in
response to infection and inflammation however functional
data is required to substantiate this hypothesis.
The exact sequence of inflammatory cells in early lung dis-
eases including CF remains poorly understood [23], however
there are some distinct differences in the pattern of macrophage
distribution between CF and controls. During foetal develop-
ment, macrophage numbers in the CF trachea increase with
age whereas numbers decreased in controls [24]. This accumu-
lation continues during childhood, with numbers of alveolar
macrophages and CC chemokines increased in the lungs of
children with CF even in the absence of infection [25]. Recent
data from children with CF show a distinct increase in the num-
ber of macrophages in both the peripheral airways (consistentwith Brennan et al. [25]) and in airway wall biopsies when
compared to controls [26]. Airway wall accumulation of macro-
phages was significantly associated with both age and chest ex-
acerbation, whilst neutrophils were scarcely observed in these
biopsies. Since evidence from the literature suggests that
changes in the macrophage homeostasis are occurring prior to
the neutrophilic inflammation that is typically associated with
CF lung disease, and small macrophages display functional im-
maturity [9,10,27], any increase in the number of functionally
immature macrophages could therefore be an important step
in the intense inflammation cycle that follows.
There are a number of limitations in this study. Ethical con-
siderations prevented us from obtaining BAL from healthy
infants and children and assessing the number of small macro-
phages in the normal lung, thus we cannot definitively answer
whether the observations in the CF cohort are the result of
lung disease. The lack of healthy BAL samples for comparison
also hindered accurately delineating the small macrophage pop-
ulation in paediatric BAL. Further adult studies may identify
distinct receptor expression patterns that assist identification
of small macrophages in the future. Finally, the small study
size and technical limitations restricted us from assessing the
function of the small macrophages discussed in this study and
larger, longitudinal studies are required to address these issues.
Fig. 3. Small macrophages in paediatric BAL. This figure provides a comparison between representative samples of BAL from a child with cystic fibrosis (a) and
a disease control (b).
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of small macrophages between disease control and CF paediat-
ric groups, our control samples exhibited higher levels of small
macrophages than the levels reported previously (Table 3). A
trend for smaller macrophage size in children under 2 years of0 1 2 3
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dren with a history of respiratory symptoms sufficiently signif-
icant to warrant a clinically indicated bronchoscopy. Thus it
is possible that these children had a pre-existing pulmonary in-
flammatory burden, perhaps similar to the inflammation seen in
infants with persistent wheezing [28,30], with an associated
macrophage degradation and monocyte recruitment resulting
in an elevated small macrophages population. However, the
observation of small macrophages within a non-CF population
shows this phenomenon is not specific to the inflammatory
milieu of CF.
In summary, this is the first study to demonstrate the pres-
ence of small macrophages in the lower airways of young chil-
dren with CF and with non-CF respiratory symptoms,
demonstrating that these cells are not specific to CF. Small
macrophages were not associated with features of worse in-
flammation and this study is unable to identify if small macro-
phages are an important factor in the inflammatory process. Yet
the observation of fewer numbers of small macrophages in
these children with typically mild disease, when compared to
adult CF subjects with long term severe disease, does suggest
the establishment of the adult small macrophage phenotype
may be related to chronicity of inflammation and infection
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